NEWS
EUROPEAN PATENT APPLICATION GRANTED FOR INHIBITORS OF THE uPAR/FPRs RECEPTOR INTERACTION
January 7, 2026
Rome, 7 January 2026 – Cube Labs S.p.A. (“Cube Labs” or the “Company”) – an Italian venture builder in the healthcare technology sector listed on
Orpha Biotech Receives Seed Capital From CDP’s Southern Italy Business Fund
July 15, 2020
Orpha Biotech has received seed investment from CDP Venture Capital – National Innovation Fund of Italy’s “Italy Venture II – Southern Italy Business Fund.” The